Literature DB >> 2213824

Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.

T Rosen1, A A Nagel, J P Rizzi, J L Ives, J B Daffeh, A H Ganong, K Guarino, J Heym, S McLean, J T Nowakowski.   

Abstract

A novel structural class of highly potent and selective 5-HT3 receptor antagonists is described. The compounds in this new series contain a thiazole moiety linking an aromatic group and a nitrogen-containing basic region; the thiazole group appears to be acting as a carbonyl bioisostere in this system. An optimized member of this series, 4-(2-methoxyphenyl)-2-[[4(5)-methyl-5(4)-imidazolyl]methyl]thiazole (5), exhibits oral activity in the Bezold-Jarisch reflex paradigm comparable to or better than the standard agents ondansetron (1) and ICS-205-930 (2). Several of the structure-activity relationships are rationalized in terms of a computer pharmacophore model for 5-HT3 receptor binding.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213824     DOI: 10.1021/jm00172a006

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Structure-based 3D-QSAR studies on thiazoles as 5-HT3 receptor antagonists.

Authors:  Li-Ping Zhu; De-Yong Ye; Yun Tang
Journal:  J Mol Model       Date:  2006-09-05       Impact factor: 1.810

2.  Imidazole-containing (N3S)-Ni(II) complexes relating to nickel containing biomolecules.

Authors:  Roxanne M Jenkins; Michael L Singleton; Elky Almaraz; Joseph H Reibenspies; Marcetta Y Darensbourg
Journal:  Inorg Chem       Date:  2009-08-03       Impact factor: 5.165

3.  Characterizing ligand-gated ion channel receptors with genetically encoded Ca2++ sensors.

Authors:  John G Yamauchi; Ákos Nemecz; Quoc Thang Nguyen; Arnaud Muller; Lee F Schroeder; Todd T Talley; Jon Lindstrom; David Kleinfeld; Palmer Taylor
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

4.  5-HT3 receptor antagonism a potential therapeutic approach for the treatment of depression and other disorders.

Authors:  Shvetank Bhatt; Thangaraj Devadoss; Santhepete Nanjundaiah Manjula; Jayaraman Rajangam
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

Review 5.  Applications of organocatalysed visible-light photoredox reactions for medicinal chemistry.

Authors:  Michael K Bogdos; Emmanuel Pinard; John A Murphy
Journal:  Beilstein J Org Chem       Date:  2018-08-03       Impact factor: 2.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.